ReviewJournal of clinical medicine2022

Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?

Peter Blaško et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.